Acceptability of DNA Markers in Vaginal Fluid for Endometrial Cancer Detection

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study explores how women respond to the idea of testing DNA markers in vaginal fluid as a potential method for early detection of endometrial cancer. Participants are self-identified Black individuals aged 45 or older with an intact uterus who have experienced abnormal uterine or post-menopausal bleeding. The study uses a non-interventional design with a 45-minute virtual interview to assess acceptability and perspectives. Lead coordination is via Mayo Clinic in Rochester, Minnesota, with Mayo as the sponsor and no collaborators listed.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Self-identified Black individuals ≥ 45 years with an intact uterus
* Assigned female sex at birth
* Experience with abnormal uterine or post-menopausal bleeding (defined as vaginal bleeding between periods, heavy vaginal bleeding, vaginal bleeding after menopause, and/or red, brown, or pink colored vaginal discharge after menopause)
* Willing to participate in a 45-minute virtual interview

Exclusion Criteria:

* Previous or current diagnosis of endometrial cancer

Where it's running

• Mayo Clinic in Rochester
  Rochester, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Shariska Harrington, MD — Mayo Clinic in Rochester
• Study coordinator: Clinical Trials Referral Office
• Email: mayocliniccancerstudies@mayo.edu
• Phone: 855-776-0015

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blended e-Health Program to Help Women with Breast or Gynecologic Cancer Manage Fear of Cancer Progression

  This trial tests a blended online and group program to see if it helps women with breast or gynecologic cancer feel less fear that their cancer could grow or spread.

  Recruiting at 11 sites City of Hope Medical Center · Arcadia, California and 10 other locations · NCT07741968

• Flyte device to help urinary incontinence after pelvic radiation for endometrial or cervical cancer

  This study tests whether a home-use Flyte device, used during guided pelvic floor exercises, can improve urinary incontinence in women who had pelvic radiation for endometrial or cervical cancer.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07662824

• Improved MRI methods to distinguish benign from cancerous pelvic findings

  This test tries new deep-learning image-processing methods on MRI scans to get clearer images faster for adults scanned for prostate screening or suspected endometriosis.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07407959

• In-home cancer treatment with remote specialist support for patients in the Florida Panhandle

  This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07285044

• FT836 alone or with chemotherapy and antibody drugs for advanced solid tumors.

  This trial will test if FT836, given alone or with paclitaxel and/or the antibodies trastuzumab or cetuximab, is safe and tolerable for people with advanced solid tumors who have already received prior treatment.

  Recruiting at 5 sites Phase 1 Fate Therapeutics · La Jolla, California and 4 other locations · NCT07216105

• Molecular and ctDNA profiling for high-risk endometrial cancer

  This project will collect blood and tumor tissue to test whether tumor DNA and other genetic changes can help predict recurrence in people with high-risk endometrial cancer.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07062016

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.